Arctic Bioscience, a biotech company developing and commercializing nutraceutical and pharmaceutical products based on the unique properties of bioactive marine compounds, will present at the US investment bank
H.C. Wainwright Bioconnect Conference Details:
Date:
Link: Arctic Bioscience company presentation
Full event details:
A recording of the presentation will be available on the company's website from
For further information, please contact:
CFO of
Phone: +47 909 98 201
Email: danielle@arctic-bioscience.com
About Arctic Bioscience
Arctic Bioscience is a biotech company developing and commercializing nutraceutical products based on herring roe oil. Herring roe oil contains lipids that are essential to maintain cell membranes, contributing to normal functioning of brain, heart, and vision.
The company is developing HRO350 - a novel investigational drug candidate with herring roe as raw material. HRO350 is being developed for treatment of mild-to-moderate psoriasis. This is a large patient group in need of new effective medicines with beneficial safety profile. Arctic Bioscience is led by a team of highly competent people with experience in developing marine oils and experience from global pharmaceutical companies.
https://news.cision.com/arctic-bioscience-as/r/arctic-bioscience-to-present-at-h-c--wainwright-bioconnect-conference,c3482535
(c) 2022 Cision. All rights reserved., source